O	0	8	TGFbeta1	TGFbeta1	NN	B-NP
O	8	9	,	,	,	O
O	10	14	back	back	RB	B-ADVP
O	15	17	to	to	TO	B-PP
O	18	21	the	the	DT	B-NP
O	22	28	future	future	NN	I-NP
O	28	29	:	:	:	O
O	30	40	revisiting	revisit	VBG	B-VP
O	41	44	its	its	PRP$	B-NP
O	45	49	role	role	NN	I-NP
O	50	52	as	as	IN	B-PP
O	53	54	a	a	DT	B-NP
O	55	67	transforming	transform	VBG	I-NP
O	68	74	growth	growth	NN	I-NP
O	75	81	factor	factor	NN	I-NP
O	81	82	.	.	.	O

O	83	91	TGFbeta1	TGFbeta1	NN	B-NP
O	92	95	was	be	VBD	B-VP
O	96	105	initially	initially	RB	I-VP
O	106	116	identified	identify	VBN	I-VP
O	117	119	in	in	IN	B-PP
O	120	127	culture	culture	NN	B-NP
O	128	133	media	medium	NNS	I-NP
O	134	138	from	from	IN	B-PP
O	139	150	transformed	transform	VBN	B-NP
B-Cell	151	156	cells	cell	NNS	I-NP
O	157	159	as	as	IN	B-PP
O	160	164	part	part	NN	B-NP
O	165	167	of	of	IN	B-PP
O	168	169	a	a	DT	B-NP
O	170	176	factor	factor	NN	I-NP
O	177	181	that	that	WDT	B-NP
O	182	187	could	could	MD	B-VP
O	188	195	produce	produce	VB	I-VP
O	196	197	a	a	DT	B-NP
O	198	209	transformed	transform	VBN	I-NP
O	210	219	phenotype	phenotype	NN	I-NP
O	220	222	in	in	IN	B-PP
O	223	224	a	a	DT	B-NP
O	225	239	nontransformed	nontransformed	JJ	I-NP
B-Cell	240	244	cell	cell	NN	I-NP
I-Cell	245	249	line	line	NN	I-NP
O	249	250	.	.	.	O

O	251	263	Subsequently	Subsequently	RB	B-ADVP
O	264	268	this	this	DT	B-NP
O	269	277	activity	activity	NN	I-NP
O	278	281	was	be	VBD	B-VP
O	282	291	separated	separate	VBN	I-VP
O	292	296	into	into	IN	B-PP
O	297	304	TGFbeta	TGFbeta	NN	B-NP
O	305	308	and	and	CC	I-NP
O	309	317	TGFalpha	TGFalpha	NN	I-NP
O	318	320	an	an	DT	B-NP
O	321	324	EGF	EGF	NN	I-NP
O	325	333	receptor	receptor	NN	I-NP
O	334	340	ligand	ligand	NN	I-NP
O	340	341	.	.	.	O

O	342	346	With	With	IN	B-PP
O	347	350	the	the	DT	B-NP
O	351	360	discovery	discovery	NN	I-NP
O	361	365	that	that	IN	B-SBAR
O	366	374	TGFbeta1	TGFbeta1	NN	B-NP
O	375	378	was	be	VBD	B-VP
O	379	380	a	a	DT	B-NP
O	381	387	potent	potent	JJ	I-NP
O	388	394	growth	growth	NN	I-NP
O	395	404	inhibitor	inhibitor	NN	I-NP
O	405	407	of	of	IN	B-PP
B-Cell	408	418	epithelial	epithelial	JJ	B-NP
I-Cell	419	424	cells	cell	NNS	I-NP
O	424	425	,	,	,	O
O	426	429	and	and	CC	O
O	430	433	the	the	DT	B-NP
O	434	448	identification	identification	NN	I-NP
O	449	451	of	of	IN	B-PP
O	452	464	inactivating	inactivate	VBG	B-VP
O	465	474	mutations	mutation	NNS	B-NP
O	475	481	within	within	IN	B-PP
O	482	485	the	the	DT	B-NP
O	486	494	TGFbeta1	TGFbeta1	NN	I-NP
O	495	504	signaling	signaling	NN	I-NP
O	505	512	pathway	pathway	NN	I-NP
O	513	515	in	in	IN	B-PP
B-Cancer	516	523	cancers	cancer	NNS	B-NP
O	524	526	it	it	PRP	B-NP
O	527	533	became	become	VBD	B-VP
O	534	539	clear	clear	JJ	B-ADJP
O	540	544	that	that	IN	B-SBAR
O	545	553	TGFbeta1	TGFbeta1	NN	B-NP
O	554	563	signaling	signaling	NN	I-NP
O	564	566	is	be	VBZ	B-VP
O	567	568	a	a	DT	B-NP
B-Cancer	569	574	tumor	tumor	NN	I-NP
O	575	585	suppressor	suppressor	NN	I-NP
O	586	593	pathway	pathway	NN	I-NP
O	594	597	for	for	IN	B-PP
O	598	603	early	early	JJ	B-NP
O	604	610	stages	stage	NNS	I-NP
O	611	613	of	of	IN	B-PP
B-Cancer	614	620	cancer	cancer	NN	B-NP
O	620	621	.	.	.	O

O	622	629	However	However	RB	B-NP
O	630	634	many	many	JJ	I-NP
O	635	640	human	human	JJ	I-NP
B-Cancer	641	651	carcinomas	carcinoma	NNS	I-NP
O	652	663	overexpress	overexpres	VBP	B-VP
O	664	672	TGFbeta1	TGFbeta1	NN	B-NP
O	673	676	and	and	CC	O
O	677	681	this	this	DT	B-NP
O	682	684	is	be	VBZ	B-VP
O	685	695	associated	associate	VBN	I-VP
O	696	700	with	with	IN	B-PP
O	701	705	poor	poor	JJ	B-NP
O	706	713	patient	patient	NN	I-NP
O	714	723	prognosis	prognosis	NN	I-NP
O	724	727	and	and	CC	O
O	728	737	increased	increase	VBN	B-NP
O	738	747	frequency	frequency	NN	I-NP
O	748	750	of	of	IN	B-PP
O	751	761	metastasis	metastasis	NN	B-NP
O	761	762	.	.	.	O

O	763	770	Similar	Similar	JJ	B-NP
O	771	778	results	result	NNS	I-NP
O	779	783	have	have	VBP	B-VP
O	784	788	been	be	VBN	I-VP
O	789	797	obtained	obtain	VBN	I-VP
O	798	802	with	with	IN	B-PP
B-Cell	803	808	tumor	tumor	NN	B-NP
I-Cell	809	813	cell	cell	NN	I-NP
I-Cell	814	819	lines	line	NNS	I-NP
O	820	823	and	and	CC	O
O	824	836	experimental	experimental	JJ	B-NP
O	837	843	animal	animal	NN	I-NP
O	844	850	models	model	NNS	I-NP
O	850	851	.	.	.	O

O	852	856	Thus	Thus	RB	B-NP
O	857	862	stage	stage	NN	I-NP
O	863	871	specific	specific	JJ	I-NP
O	872	879	duality	duality	NN	I-NP
O	880	882	of	of	IN	B-PP
O	883	891	function	function	NN	B-NP
O	892	894	is	be	VBZ	B-VP
O	895	898	the	the	DT	B-NP
O	899	907	emerging	emerge	VBG	I-NP
O	908	916	paradigm	paradigm	NN	I-NP
O	917	920	for	for	IN	B-PP
O	921	924	the	the	DT	B-NP
O	925	929	role	role	NN	I-NP
O	930	932	of	of	IN	B-PP
O	933	941	TGFbeta1	TGFbeta1	NN	B-NP
O	942	944	in	in	IN	B-PP
B-Cancer	945	951	cancer	cancer	NN	B-NP
O	951	952	.	.	.	O

O	953	957	This	This	DT	B-NP
O	958	964	review	review	NN	I-NP
O	965	969	will	will	MD	B-VP
O	970	975	focus	focus	VB	I-VP
O	976	978	on	on	IN	B-PP
O	979	982	the	the	DT	B-NP
O	983	991	evidence	evidence	NN	I-NP
O	992	995	for	for	IN	B-PP
O	996	1004	TGFbeta1	TGFbeta1	NN	B-NP
O	1005	1007	as	as	IN	B-PP
O	1008	1009	a	a	DT	B-NP
B-Cancer	1010	1015	tumor	tumor	NN	I-NP
O	1016	1025	promoting	promoting	NN	I-NP
O	1026	1029	and	and	CC	O
O	1030	1040	metastasis	metastasis	NN	B-NP
O	1041	1047	factor	factor	NN	I-NP
O	1048	1051	and	and	CC	O
O	1052	1059	examine	examine	VB	B-VP
O	1060	1063	the	the	DT	B-NP
O	1064	1074	biological	biological	JJ	I-NP
O	1075	1078	and	and	CC	I-NP
O	1079	1088	molecular	molecular	JJ	I-NP
O	1089	1094	basis	basis	NN	I-NP
O	1095	1098	for	for	IN	B-PP
O	1099	1104	these	these	DT	B-NP
O	1105	1112	effects	effect	NNS	I-NP
O	1112	1113	.	.	.	O

O	1114	1116	It	It	PRP	B-NP
O	1117	1119	is	be	VBZ	B-VP
O	1120	1128	proposed	propose	VBN	I-VP
O	1129	1133	that	that	IN	B-SBAR
O	1134	1137	the	the	DT	B-NP
O	1138	1144	switch	switch	NN	I-NP
O	1145	1149	from	from	IN	B-PP
B-Cancer	1150	1155	tumor	tumor	NN	B-NP
O	1156	1166	suppressor	suppressor	NN	I-NP
O	1167	1169	to	to	TO	B-PP
O	1170	1178	oncogene	oncogene	NN	B-NP
O	1179	1187	reflects	reflect	VBZ	B-VP
O	1188	1195	genetic	genetic	JJ	B-NP
O	1196	1198	or	or	CC	I-NP
O	1199	1209	epigenetic	epigenetic	JJ	I-NP
O	1210	1221	alterations	alteration	NNS	I-NP
O	1222	1224	in	in	IN	B-PP
O	1225	1234	signaling	signaling	NN	B-NP
O	1235	1243	pathways	pathway	NNS	I-NP
O	1244	1246	in	in	IN	B-PP
B-Cell	1247	1252	tumor	tumor	NN	B-NP
I-Cell	1253	1258	cells	cell	NNS	I-NP
O	1259	1263	that	that	WDT	B-NP
O	1264	1269	alter	alter	VBP	B-VP
O	1270	1273	the	the	DT	B-NP
O	1274	1281	readout	readout	NN	I-NP
O	1282	1286	from	from	IN	B-PP
O	1287	1290	the	the	DT	B-NP
O	1291	1299	TGFbeta1	TGFbeta1	NN	I-NP
O	1300	1307	pathway	pathway	NN	I-NP
O	1307	1308	.	.	.	O

